Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain

• Published in: European journal of public health Vol. 18; no. 6; pp. 674 - 680
• Main Authors: Gauthier, Aline, Martín-Escudero, Victoria, Moore, Lee, Ferko, Nicole, de Sanjosé, Silvia, Pérez-Escolano, Isabel, Catalá-López, Ferrán, Ferrer, Elena, Bosch, F. Xavier
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.12.2008; Oxford Publishing Limited (England)
• Subjects: Adaptation; Adolescent; Adult; Age; Aged; Calibration; Cancer vaccines; Cellular biology; Cervical cancer; Child; Epidemiology; Family planning; Female; Human papillomavirus; Human papillomavirus 16; Human papillomavirus 16 - immunology; Human papillomavirus 18 - immunology; Humans; Immunization; Incidence; Infections; Markov Chains; Mass Screening; Medical screening; Middle Aged; Models, Statistical; Natural history; Papillomavirus Infections - prevention & control; papillomavirus vaccines; Papillomavirus Vaccines - therapeutic use; Prevalence; Public health; Sensitivity and Specificity; Spain; uterine cervical neoplasms; Uterine Cervical Neoplasms - prevention & control; Vaccines; Womens health; Spain; mass screening; papillomavirus vaccines; uterine cervical neoplasms; Spain

Background: Human papillomavirus (HPV) epidemiology and screening practices vary considerably between countries and specific analyses are required to estimate the impact of HPV vaccination. This study aimed to predict the clinical benefits of introducing a bivalent HPV16/18 vaccine in Spain, where t...